AI assistant
Sending…
DEXCOM INC — Director's Dealing 2020
Dec 19, 2020
30198_dirs_2020-12-18_12b8ccda-84d6-433b-b0e4-cb787e504072.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-12-16
Reporting Person: AUGUSTINOS NICHOLAS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-16 | Common Stock | S | 600 | $352.2 | Disposed | 13242 | Indirect |
| 2020-12-16 | Common Stock | S | 25 | $354.0 | Disposed | 13217 | Indirect |
| 2020-12-16 | Common Stock | S | 625 | $356.82 | Disposed | 12592 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 806 | Direct |
Footnotes
F1: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.
F2: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17